Navigation Links
Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma
Date:12/3/2010

er of 2011, that CTI's appeal may not be successful, that the FDA may not approve CTI's SPA, that the EMA may not approve CTI's MAA after review and CTI's ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.Media Contact:Dan Eramian T: 206.272.4343C: 206.854.1200E: deramian@ctiseattle.comKristin MacIntoshT: 206.272.4490E: kmacintosh@ctiseattle.comwww.CellTherapeutics.com/press_room Investors Contact:Ed BellT: 206.282.7100Lindsey Jesch LoganT: 206.272.4347F: 206.272.4434E: invest@ctiseattle.com www.CellTherapeutics.com/investorsMedical Information Contact:T: 800.715.0944E: info@askarm.com
'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 San MediTech, the ... continuous glucose monitoring (CGM) for diabetics, announced its plan ... Sessions in Boston on June ... their newest Dynamic Glucose Monitoring System (DGMS). The company ... the world the innovative technologies and advancements made by ...
(Date:6/2/2015)... Mass. , June 2, 2015  PROMETRIKA, ... expanded its offerings with the addition of pharmacovigilance ... a world leader in safety data collection and ... and regulatory affairs professionals, and expert physicians, each ... provide clinical interpretation and monitoring of safety trends. ...
(Date:6/2/2015)... June 2, 2015  Psychemedics Corporation (NASDAQ: PMD ... twenty-five years, announced the addition of 2 new drugs ... growing abuse concerns, the addition of Oxymorphone was made ... added as an option to the Amphetamine panel. ... stated:  "Sadly, more and more prescription drugs are being ...
Breaking Medicine Technology:San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4PROMETRIKA Announces the Availability of Pharmacovigilance Services 2Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3
... on the success of their revolutionary soft cloth nasal ... proud to introduce a mask tube so lightweight and ... Used in the treatment of sleep apnea, ... the CPAP mask with a 15-millimeter hose composed of ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: ... that discovers and develops new uses for previously ... announced that an IRB approved, randomized, vehicle-controlled, double-blinded ... in Denver, Colorado indicates that Ampion™ provides safe ...
Cached Medicine Technology:Circadiance Launches Revolutionary New CPAP Tube 2Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation 2Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation 3
(Date:6/2/2015)... 02, 2015 For those that have ... exposed to harmful germs, chemicals and bodily fluids from ... to an inventor from Queens Village, N.Y., their worries ... an efficient, fun, hygienic way to store and dispense ... to bugs, chemicals and germs. Furthermore, it insures that ...
(Date:6/2/2015)... NC (PRWEB) June 02, 2015 ... training and compliance solutions for the healthcare market, ... The Arc to offer 10 complimentary courses relating ... provide public safety professionals with additional resources to ... Safety professionals are often the first responders to ...
(Date:6/2/2015)... 02, 2015 Recent findings from the ... while there has been a reduction in conventional cigarette ... waterpipe vapor (hookah) usage has doubled among today’s teens ... Russell Gombosi believes the national trend is consistent with ... 15 to 20 years to fully determine the long-term ...
(Date:6/2/2015)... Glidewell Laboratories, industry-leading provider of ... the new issue of Chairside® magazine, its restorative-dentistry-focused ... The digital edition of the latest issue, Volume ... of the dental laboratory’s magazine, can be viewed ... by visiting http://www.chairsidemagazine.com . , In the ...
(Date:6/2/2015)... 02, 2015 Residents of Monarch Landing ... swim, take a fitness class, do yoga, play volleyball, ... In preparation for the Alzheimer’s Association’s Walk to End ... will take part in a challenge to exercise for ... Landing’s management company. , While the walk will raise ...
Breaking Medicine News(10 mins):Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 3Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 2Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 3Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 2Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 3Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3
... intimate partners spent 42 percent more on health care per ... more than 3,000 women. , And the costs don,t end ... suffered physical abuse five or more years earlier still spent ... who were never abused. , "Along with all the physical ...
... Services, Inc. announced today that it has provided ... Hospital in Mountain View, California. The five-year tax-exempt ... Siemens Medical Solutions equipment which will be deployed ... http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )"For more than 40 years, ...
... Kiley Carlson of Sioux City, IA will travel to ... 2009 to meet with congressional leaders and gain their ... toward a cure for epilepsy.Carlson, 16, is one of ... Kids Speak Up! , a national program coordinated ...
... 23 Fujirebio Diagnostics, Inc., the premier cancer ... biomarker assays, today announced the appointment of Grady ... Barnes comes to Fujirebio Diagnostics with 25 years ... positions at Abbott and Meridian Bioscience, most recently ...
... demonstrated how a single-celled organism, living freely in the ... transmission to animals and humans. , Salmonella ... food type, causing diarrhoea, abdominal pain and fever. ... also cause typhoid fever has evolved unique mechanisms ...
... access to largest portfolio of clinical laboratory ... Healthcare ( www.siemens.com/diagnostics ) and Sysmex Corporation ... of a five-year contract renewal for a ... Under the agreement, clinical laboratory customers around ...
Cached Medicine News:Health News:Physical abuse raises women's health costs over 40 percent 2Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 2Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 3Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2Health News:Fujirebio Diagnostics Appoints Grady Barnes as Chief Scientific Officer 2Health News:Study shows how Salmonella survives in environment 2Health News:Siemens and Sysmex Renew Global Agreement 2Health News:Siemens and Sysmex Renew Global Agreement 3
TOPLOAD 3200/0.01G, BL3200H. Touch-key external calibration only. Requires calibration weights (either 2000g or 3000g). 120/240V A/C adapter, Lock-down Ring, In-use Protective Cover....
... Portable - Battery Powered (6 size ... Unit conversion (g, ct, oz, ozt, GN, ... Piece Counting and Percent Measure functions, Auto ... operation. Optional AC adapter may be ordered ...
... speed, stability and durability. Back-lighted Display. ... multiple units of measure, piece counting ... and GLP/GMP/ISO output including date and ... calibration with external weights only (selectable ...
60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure....
Medicine Products: